LAURA DAVIS: Open Payments
NPI 1154571446 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,112 in 91 payments from 9 companies in 2025. Trend: 2023 $1,757 · 2024 $1,288 · 2025 $2,112
Food & beverage: $2,112
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 15 | $740 |
| Medtronic, Inc. | 18 | $531 |
| Collegium Pharmaceutical, Inc. | 32 | $372 |
| ABBVIE INC. | 15 | $224 |
| DePuy Synthes Sales Inc. | 3 | $84 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $69 |
| PFIZER INC. | 3 | $55 |
| SPR Therapeutics, Inc | 1 | $23 |
| Abbott Laboratories | 1 | $15 |
Products named: Intracept, INCEPTIV, Belbuca, SYNCHROMEDII, BOTOX, QULIPTA, JOURNAVX, MONOVISC.
Industry payments across VA — which companies pay providers there.
